Arkolith/Insider Trading/SCPS/Form 4

Lamstein Joshua R

Chairman, Director, 10% OwnerScopus BioPharma Inc. (SCPS) · full profile →Form 4 · filed Aug 3, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
0 non-derivative · 4 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 31, 2021Other(J)0———
Jul 31, 2021Other(J)0———
Jul 31, 2021Conversion(C)1.1M——1.1M
Jul 31, 2021Other(J)17K——31K

Transaction Codes

J
Other acquisition / disposition
C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-21-099626) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML